Avrupa Birliği - İzlandaca - EMA (European Medicines Agency)

roche registration gmbh - mosunetuzumab - eitilæxli, follicular - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.

Avrupa Birliği - İzlandaca - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 og 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 og 5.

Avrupa Birliği - İzlandaca - EMA (European Medicines Agency)

janssen-cilag international n.v. - talquetamab - mergæxli - Æxlishemjandi lyf - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Avrupa Birliği - İzlandaca - EMA (European Medicines Agency)

janssen-cilag international n.v. - teclistamab - mergæxli - Æxlishemjandi lyf - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

n.v. organon* - betamethasonum díprópíónat; acidum salicylicum - húðlausn

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

grünenthal gmbh* - esomeprazolum magnesíum - mixtúrukyrni, dreifa - 10 mg

Avrupa Birliği - İzlandaca - EMA (European Medicines Agency)

torbet laboratories ireland limited - urea (13c) - breath tests; helicobacter infections - greiningarefni - Þetta lyf er eingöngu ætlað til greiningar. fyrir í lífinu greiningu á maga helicobacter haf (h. haf) sýkingu.

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - rabeprazolum natríum - magasýruþolin tafla - 20 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - omeprazolum inn - magasýruþolið hart hylki - 40 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - omeprazolum inn - magasýruþolið hart hylki - 20 mg